Severe obesity and insulin resistance. Result obtained by the bilio-pancreatic diversion independentely for an associated gastroresection or gastropreservation;Obesità grave e insulino resistenza. Risoluzione indotta dalla diversione biliopancreatica indipendentemente dalla gastroresezione o gastroconservazione associata

Annali Italiani di Chirurgia

Volumn 78, Issue 3, 2007, Pages 201-207

  Di Betta, Ernesto ^a   Mittempergher, Francesco ^a   Terraroli, Carmen ^a   Valloncini, Eleonora ^a   Salerni, Bruno ^a  

^a UNIVERSITY OF BRESCIA   (Italy)

Author keywords

Body Mass Index; Insulin resistance; Type 2 diabetes

Indexed keywords

ADULT; ARTICLE; BILIOPANCREATIC BYPASS; FEMALE; HOSPITALIZATION; HUMAN; INSULIN RESISTANCE; MALE; METHODOLOGY; MIDDLE AGED; OBESITY; PROSPECTIVE STUDY; STOMACH;

ADULT; BILIOPANCREATIC DIVERSION; FEMALE; HUMANS; INSULIN RESISTANCE; MALE; MIDDLE AGED; OBESITY; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; STOMACH;

EID: 38449089525     PISSN: 0003469X     EISSN: 2239253X     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Kahn BB, Flier JS: Obesity and insulin resistance. J Clin Invest 2000; 106:473-81.
2. De Fronzo RA: Pathogenesis of type 2 diabetes metabolic and molecular implications for identifying diabetes genes. Diabetes Rev 1997; 5:177-269.
3. Buffington CK, Cowan GS: Gastric bypass in the treatment of diabetes, hypertension and lipid/lipoprotein abnormalities of the morbidly obese. Update: surgery for the morbidly obese patient 2000: 434-49 Eds Toronto, FD-Communications.
4. Katz A, Nambi SS, Mather K, Baron A.D., Follmann AD, Sullivan G, Quon MJ: Quantitative Insuline Sensitivity Check Index: a simple accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab, 2000; 85:2402-410.
5. Matthews DR, Hosker JP, Rudenski AS: Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentration in man. Diabetologia 1985; 28:412-19.
6. Buchwald H, Buchwald JN: Evolution of operative procedures for the management of morbid obesity 1950-2000 (Collective review). Obes Surg 2002; 12:705-17.
7. Expert Committee on the diagnosis and classification of diabetes mellitus: Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care, 1997; 20:1183-197.
8. Scopinaro N, Adami GF, Marinari G.M., Gianetta E., Traverso E, Friedman D, Camerini G., Banchieri G, Simonelli A: Biliopancreatic Diversion. World J Surg 1998; 22:936-48.
9. Vassallo C, Negri L, Delia Valle A, Salvaneschi M, Vegezzi C., Griziotti A, Dono C, Mussi P., Bausardo MG, Pietrobono P: Biliopancreatic diversion with transitory gastroplasty preserving duodenal bulb: 3 years experience. Obes Surg 1997; 7(1):30-3.
10. Rubino F, Gagnè M: Potential of surgery for curing type II diabetes mellitus. Ann Surg 2002; 236(5):554-59.
11. Poirier P, Eckel RH: Obesity and cardiovascular disease. Curr Atheroscler Rep 2002; 4:448-53.
12. Allison DB, Fontaine KR, Manson J.E., Steven J., Vanitallie TB: Annual deaths attributable to obesity in the USA. JAMA 1999; 282:1530-538.
13. Drenick EJ, Bale JS, Seltzer F, Johnson DG: Excessive mortality and causes of death in morbidly obese men. JAMA 1980; 243:443-45.
14. Manson JE, Willet WC, Stampfer M.J., Colditz JA, Hunter DJ, Hankinson SE, Hennekens C.H., Speizer FE: Body weight and mortality among women. N Engl J Med 1995; 333:677-85.
15. Stevens J, Cai J, Pamuk E.R., Williamson DF, Thun MJ, Wood JL: The effect of age on the association between Body Mass Index and mortality. N Engl J Med 1998; 338:1-7.
16. Colditz JA, Willett WC, Rottnittzky A, Manson JE: Weight gain as risk factor for clinical diabetes mellitus in women. Ann Intern Med 1995; 122:481-86.
17. Field AE, Coakley EH, Must A, Spadano J.L., Laird N., Dietz WH, Rimm E, Colditz JA: Impact of overweight on the risk of developing common chronic diseases during a ten period. Arch Intern Med 2001; 161:1581-586.
18. Brunzel JD, Roberson RP, Lerner R.L., Hazard WR, Ennsinck JW, Bierman EL, Porte DJr: Relationship between fasting plasma glucose levels and insulin secretion during intravenous glucose tolerance tests. J Clin Endocrinol Metab 1976; 42:222-29.
19. Weir GC, Bonner-Weir S: Insulin secretion in non insulin dependent diabetes mellitus. In Diabetes Mellitus Philadelphia: Lippincott, Williams and Wilkins 2000; 595-603.
20. Kahn SE: The importance of b-cell failure in the development and progression of type 2 diabetes. J Clin Endocrinol Metab: 2001; 86:4047-058.
21. Weyer C, Bogardus C, Mott D.M., Pratley RE: The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus. J Clin Invest: 1999; 104:787-94.
22. Cowan GS, Buffington CK: Significant changes in blood pressure, glucose and lipids with gastric bypass surgery. World J Surg, 1998; 22:986-93.
23. Smith SC, Edwards CB, Goodman GN: Changes in diabetic management after Roux-en-Y gastric bypass. Obes Surg, 1996; 6:345-48.
24. Mac Donald Jr KG, Long SD, Swanson M.S., Brown BM, Morris P, Dohm GL, Pories WJ: The gastric bypass operation reduces the progression and mortality of non-insulin dependent diabetes mellitus, J Gastrointest Surg, 1997; 1:213-20.
25. Weyer C, Hanson K, Bogardus C., Pratley RE: Long-term changes in insulin action and insulin secretion associated with gain, loss regain and manteinance of body weight. Diabetologia, 2000; 43:36-46.
26. rd, Klein S: Effects of obesity surgery on non insulin dependent diabetes mellitus. Arch Surg, 2002; 137(10):1109-117.
27. Marceau P, Hould FS, Simard S, Lebel S., Bourque RA, Potvin M, Byron S: Biliopancreatic diversion with duodenal switch. World J Surg, 1998; 22:947-54.
28. Livingston EH: Obesity and its surgical management. Am J Surg 2002; 184:103-13.
29. Sileo F, Bonassi U, Bolognini C., Miglioranzi A, Possenti A, Svanoni F., Tengattini F, Tintorio A, Pagani G: Biliopancreatic bypass in the treatment of severe obesity: long term clinical, nutritional and metabolic evaluation. Minerva Gastroenterol Dietol, 1995; 41:149-155.
30. Noya G, Cossu ML, Coppola M, Tomolo G., Angius MF, Fais E, Ruggiu M: Biliopancreatic diversion preserving stomach and pylorus in the treatment of hypercolesterolemia and diabetes type II: Results in the first 10 cases. Obes Surg 1998; 8:67-72.
31. Polyzogopoulou EV, Kalfarentzos F, Vagenakis A.G., Alexandrides TK: Restoration of euglycemia and normal acute insulin response to glucose in obese subject with type II diabetes following bariatric surgery. Diabetes, 2003; 52:1098-103.
32. Frigg A, Poterli R, Petrs T., Ackermann C, Tondelli P: Reduction in co-morbidities 4 years after laparoscopic adjustable gastric banding. Obes Surg, 2004; 14(2):216-23.
33. Mittempergher F, Bruni T, Bruni O., Di Betta E, Occelli G, Salerni B: La diversione biliopancreatica con conservazione del bulbo duodenale e gastroplastica transitoria nel trattamento delTobesità patologica. Nostra esperienza. Ann Ital Chir, 2002; 2:137-42.